A.R.T. Advisors, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$730,000
+224.4%
40,102
+498.3%
0.04%
+184.6%
Q1 2019$225,000
-90.8%
6,703
-91.0%
0.01%
-91.7%
Q4 2018$2,446,000
+71.9%
74,416
+218.8%
0.16%
+141.5%
Q3 2018$1,423,000
-85.0%
23,346
-88.0%
0.06%
-83.2%
Q2 2018$9,514,000
+3347.1%
194,846
+766.0%
0.39%
+2318.8%
Q4 2016$276,000
-23.8%
22,500
-14.7%
0.02%0.0%
Q1 2016$362,000
-71.7%
26,376
-75.1%
0.02%
-76.5%
Q1 2014$1,281,000
-49.7%
105,724
-52.9%
0.07%
-49.6%
Q4 2013$2,546,000224,3200.14%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders